The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

IBM is seeking a long-term partnership with Japan's Rapidus to develop sub-1nm chips, according to . Building on their 2nm collaboration, IBM has deployed engineers to Rapidus's Hokkaido site ...

A veteran drug development leader, Dr. Ivarsson most recently served as Senior Vice President and Chief Development Officer at Moderna, where she was honored as an Officer of the Order of the ...

PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr.

Image source: Getty Images. That surely came as a relief to Moderna investors, since the company's latest stock-rattling news was its withdrawal of a Food and Drug Administration application for a ...

It was a small “Windows add-on program” for AOL, and it wasn’t made by a software company, but by a hacker calling themselves ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...